Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia
Among parturients with early gestational or pre-existing type 2 diabetes, the addition of metformin to insulin was not associated with lower odds of preterm preeclampsia or with serum biomarkers associated with cardiovascular disease risk.
Authors
- Mark B. Landon
- Wadia Mulla
- Kim Boggess
- Ashley N. Battarbee (ORCID: https://orcid.org/0000-0002-4837-8059)
- Christina Scifres (ORCID: https://orcid.org/0000-0003-2992-7187)
- Sherri Longo (ORCID: https://orcid.org/0000-0003-4781-7037)
- Todd Rosen (ORCID: https://orcid.org/0000-0001-5810-5129)
- Kedra Wallace (ORCID: https://orcid.org/0000-0003-4511-0046)
- Kacey Eichelberger (ORCID: https://orcid.org/0000-0003-4519-3929)
- Noelia Zork (ORCID: https://orcid.org/0000-0001-8675-1806)
- Kjersti Marie Aagaard (ORCID: https://orcid.org/0000-0002-2960-0371)
- Amy M. Valent (ORCID: https://orcid.org/0000-0003-3832-2024)
- Gayle Olson
- Maya Patel (ORCID: https://orcid.org/0009-0002-1662-8858)
- Celeste Durnwald (ORCID: https://orcid.org/0000-0003-1751-2312)
- Jerrie Refuerzo
- Gladys A. Ramos
Institutions
- The University of Texas Medical Branch at Galveston (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Obstetrics and Gynecology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1097/aog.0000000000005720
- Citations
- 4
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- American Diabetes Association
- National Institute of Diabetes and Digestive and Kidney Diseases